Interleukin-1 receptor-associated kinase 3 gene associates with susceptibility to acute lung injury.
暂无分享,去创建一个
M. Pino-Yanes | L. Blanch | Xiaoguang Sun | A. Corrales | J. Villar | C. Flores | J. Blanco | Joe G. N. Garcia | L. Pérez-Méndez | E. Espinosa | A. Muriel | P. Tejera | Shwu-Fan Ma | Almudena Corrales
[1] P. Ward. Immunosuppression in sepsis. , 2011, JAMA.
[2] Arthur S Slutsky,et al. Mechanical ventilation modulates Toll-like receptor signaling pathway in a sepsis-induced lung injury model , 2010, Intensive Care Medicine.
[3] L. Notarangelo,et al. Defect of regulatory T cells in patients with Omenn syndrome. , 2010, The Journal of allergy and clinical immunology.
[4] Kai Wang. Testing for genetic association in the presence of population stratification in genome‐wide association studies , 2009, Genetic epidemiology.
[5] N. Maca-Meyer,et al. A common haplotype of the LBP gene predisposes to severe sepsis * , 2009, Critical care medicine.
[6] J. Granger,et al. Stratification is the key: Inflammatory biomarkers accurately direct immunomodulatory therapy in experimental sepsis* , 2009, Critical care medicine.
[7] T. van der Poll,et al. Immunosuppression associated with interleukin-1R-associated-kinase-M upregulation predicts mortality in Gram-negative sepsis (melioidosis) , 2009, Critical care medicine.
[8] J. Ioannidis,et al. STrengthening the REporting of Genetic Association Studies (STREGA)— An Extension of the STROBE Statement , 2009, PLoS medicine.
[9] Jesús Blanco,et al. Incidence, organ dysfunction and mortality in severe sepsis: a Spanish multicentre study , 2008, Critical care.
[10] M. Daly,et al. Genetic Mapping in Human Disease , 2008, Science.
[11] J. Villar,et al. A quality assessment of genetic association studies supporting susceptibility and outcome in acute lung injury , 2008, Critical care.
[12] T. Standiford,et al. Immunosuppression in sepsis. , 2008, Current pharmaceutical design.
[13] Xiaoquan Wen,et al. Association studies for untyped markers with TUNA , 2008, Bioinform..
[14] J. Banchereau,et al. Pyogenic Bacterial Infections in Humans with MyD88 Deficiency , 2003, Science.
[15] K. Mossman. The Wellcome Trust Case Control Consortium, U.K. , 2008 .
[16] R. Kacmarek,et al. A CXCL2 polymorphism is associated with better outcomes in patients with severe sepsis* , 2007, Critical care medicine.
[17] Gonçalo R. Abecasis,et al. Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma , 2007, Nature.
[18] R. Williams,et al. Susceptibility to severe streptococcal sepsis: use of a large set of isogenic mouse lines to study genetic and environmental factors , 2007, Genes and Immunity.
[19] Simon C. Potter,et al. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls , 2007, Nature.
[20] D. Schlessinger,et al. IRAK-M is involved in the pathogenesis of early-onset persistent asthma. , 2007, American journal of human genetics.
[21] A. Sher,et al. Cooperation of Toll-like receptor signals in innate immune defence , 2007, Nature Reviews Immunology.
[22] Giorgio Sirugo,et al. A Mal functional variant is associated with protection against invasive pneumococcal disease, bacteremia, malaria and tuberculosis , 2007, Nature Genetics.
[23] I. Nolte,et al. Association of interleukin-1 receptor-associated kinase M (IRAK-M) and inflammatory bowel diseases , 2007, Scandinavian journal of gastroenterology.
[24] S. Baudouin,et al. A systematic review of the quality of genetic association studies in human sepsis , 2006, Intensive Care Medicine.
[25] T. Standiford,et al. Sepsis-induced suppression of lung innate immunity is mediated by IRAK-M. , 2006, The Journal of clinical investigation.
[26] Joaquín Dopazo,et al. PupaSuite: finding functional single nucleotide polymorphisms for large-scale genotyping purposes , 2006, Nucleic Acids Res..
[27] E. Abraham,et al. Variant IRAK-1 haplotype is associated with increased nuclear factor-kappaB activation and worse outcomes in sepsis. , 2006, American journal of respiratory and critical care medicine.
[28] N. Maca-Meyer,et al. A CXCL2 tandem repeat promoter polymorphism is associated with susceptibility to severe sepsis in the Spanish population , 2006, Genes and Immunity.
[29] Yusuke Nakamura,et al. An association study of asthma and related phenotypes with polymorphisms in negative regulator molecules of the TLR signaling pathway , 2006, Journal of Human Genetics.
[30] M. Moss. Epidemiology of sepsis: race, sex, and chronic alcohol abuse. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[31] John D. Storey,et al. A network-based analysis of systemic inflammation in humans , 2005, Nature.
[32] K. Walley,et al. Polymorphisms in CD14, mannose-binding lectin, and Toll-like receptor-2 are associated with increased prevalence of infection in critically ill adults* , 2005, Critical care medicine.
[33] D. Posthuma,et al. Heritability estimates of innate immunity: an extended twin study , 2005, Genes and Immunity.
[34] A. Hill,et al. Genetics of infectious diseases. , 2004, Human molecular genetics.
[35] N. Maca-Meyer,et al. Bench-to-bedside review: Understanding genetic predisposition to sepsis , 2004, Critical care.
[36] C. del Fresno,et al. Rapid up-regulation of IRAK-M expression following a second endotoxin challenge in human monocytes and in monocytes isolated from septic patients. , 2003, Biochemical and biophysical research communications.
[37] A. Aderem,et al. Cutting Edge: A Toll-Like Receptor 2 Polymorphism That Is Associated with Lepromatous Leprosy Is Unable to Mediate Mycobacterial Signaling1 , 2003, The Journal of Immunology.
[38] Mitchell M. Levy,et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference , 2003, Intensive Care Medicine.
[39] A. Al-ghonaium,et al. Pyogenic Bacterial Infections in Humans with IRAK-4 Deficiency , 2003, Science.
[40] Jonathan Cohen. The immunopathogenesis of sepsis , 2002, Nature.
[41] T. Kang,et al. A polymorphism in the toll-like receptor 2 is associated with IL-12 production from monocyte in lepromatous leprosy. , 2002, Cytokine.
[42] Charles A. Janeway,et al. IRAK-M Is a Negative Regulator of Toll-like Receptor Signaling , 2002, Cell.
[43] S. Ziegler,et al. Scurfin (FOXP3) Acts as a Repressor of Transcription and Regulates T Cell Activation* , 2001, The Journal of Biological Chemistry.
[44] J. Mira,et al. A Novel Polymorphism in the Toll-Like Receptor 2 Gene and Its Potential Association with Staphylococcal Infection , 2000, Infection and Immunity.
[45] D. Schwartz,et al. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans , 2000, Nature Genetics.
[46] G. Stark,et al. IRAK-M Is a Novel Member of the Pelle/Interleukin-1 Receptor-associated Kinase (IRAK) Family* , 1999, The Journal of Biological Chemistry.
[47] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .
[48] M. Lamy,et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. , 1994, American journal of respiratory and critical care medicine.
[49] C. McCall,et al. Tolerance to endotoxin-induced expression of the interleukin-1 beta gene in blood neutrophils of humans with the sepsis syndrome. , 1993, The Journal of clinical investigation.
[50] Y. Chaubey. Resampling-Based Multiple Testing: Examples and Methods for p-Value Adjustment , 1993 .